Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Amoxycillin /Potassium Clavulanate 625 Tablets bulk supplier for pharma manufacturers

Amoxycillin /Potassium Clavulanate 625 Tablets 500mg+125mg / 250mg+125mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 500mg+125mg / 250mg+125mg

Reference Brands: Augmentin (USA/EU), Co-amoxiclav (UK)

Category: Antibiotics

Amoxicillin Potassium CLavulanate Tablet is used to treat certain infections such as urinary tract infections which include inflammation of the kidney (pyelonephritis), and infection of the wall of the urinary bladder (cystitis), skin and skin structure infections such as serious bacterial skin infection (cellulitis), lower respiratory tract infections which include inflammation of the airways (bronchitis) or infection in the lungs (pneumonia).

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Amoxycillin / Potassium Clavulanate Tablets are a widely used combination antibiotic therapy designed to treat a broad range of bacterial infections. This formulation combines amoxicillin trihydrate, a penicillin-class antibiotic, with potassium clavulanate, a beta-lactamase inhibitor. Amoxicillin works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria, while clavulanate protects amoxicillin from degradation by beta-lactamase enzymes produced by resistant strains.

This combination significantly expands the spectrum of activity of amoxicillin, making it effective against both Gram-positive and Gram-negative bacteria, including those that would otherwise be resistant. It is commonly prescribed for respiratory tract infections such as sinusitis, bronchitis, and pneumonia, as well as urinary tract infections, skin and soft tissue infections, and dental infections.

Available in various tablet strengths, this medication is suitable for both outpatient and hospital use. Due to its broad-spectrum efficacy and well-established safety profile, it is one of the most commonly prescribed antibiotics worldwide, used under proper medical guidance to ensure optimal therapeutic outcomes and to minimize antibiotic resistance.

Amoxycillin /Potassium Clavulanate 625 Tablets — third party manufacturing & bulk supply

Amoxycillin /Potassium Clavulanate 625 Tablets 500mg+125mg / 250mg+125mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Amoxycillin /Potassium Clavulanate 625 Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Amoxycillin /Potassium Clavulanate 625 Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Amoxycillin /Potassium Clavulanate 625 T... →
Back to Listing

Frequently Asked Questions

Amoxycillin / Potassium Clavulanate Tablets are used to treat a wide range of bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, dental infections, and sinusitis. The combination enhances effectiveness against bacteria that produce beta-lactamase enzymes.

This combination is made from amoxicillin trihydrate, a penicillin antibiotic that kills bacteria by inhibiting cell wall synthesis, and potassium clavulanate, which acts as a beta-lactamase inhibitor to protect amoxicillin from degradation by resistant bacteria.

Common trade names include Augmentin, Clavam, Amoclan, and Co-Amoxiclav, along with various generic formulations worldwide.

Augmentin was originally developed and marketed by GlaxoSmithKline (GSK). Other brands like Clavam are marketed by Alkem Laboratories in India, and many global pharmaceutical companies manufacture generic versions.

The generic name is amoxicillin trihydrate and potassium clavulanate.

Brand names include Augmentin, Clavam, Amoclan, Co-Amoxiclav, and several regional generic brands.

This combination is manufactured globally in GMP-certified pharmaceutical facilities across the USA, Europe, India, and Latin America.

Related Products

Amoxycillin Potassium Clavulanate Suspension

Strength:
228.5 mg/5ml, 457 mg/5 ml

Form: Syrup

Reference Brands: Augmentin (USA/EU)

View Details
Amoxycillin 250Mg Suspension

Strength:
250mg

Form: Syrup

Reference Brands: Amoxil(EU), Ospamox (EU/UK)

View Details
Cefixime Dry Syrup

Strength:
25mg/ml, 50mg/5ml, 100mg/5ml

Form: Syrup

Reference Brands: Tocef Dry Syrup,

View Details
Cefixime 400 Mg Capsule

Strength:
400mg

Form: Capsules

Reference Brands: Suprax (USA)

View Details
Cloxacillin Capsules

Strength:
250 mg, 500 mg

Form: Oral Capsules

Reference Brands: Cloxacillin, Orbenin(US)

View Details
Cloxacillin Suspension

Strength:
250 mg/5 mL, 500 mg/5 mL

Form: Suspension

Reference Brands: Cloxacillin, Orbenin(US)

View Details
Cloxacillin Injectable

Strength:
1 g, 2 g

Form: Injectable (IV, IM)

Reference Brands: Cloxacillin, Orbenin(US)

View Details
Dicloxacillin Capsules

Strength:
250 mg, 500 mg

Form: Oral Capsules

Reference Brands: Dynapen(US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.